Friday 9 May 2014

Rucaparib, PF-01367338 for the treatment of patients with advanced ovarian cancer and in patients with locally advanced or metastatic breast cancer. « New Drug Approvals

Rucaparib, PF-01367338 for the treatment of patients with advanced ovarian cancer and in patients with locally advanced or metastatic breast cancer. « New Drug Approvals:



'via Blog this'

No comments:

Post a Comment